Leidos’ Roger A. Krone To Be Honored

Leidos Chairman and Chief Executive Officer Roger A. Krone Honored at the Samuel Waxman Cancer Research Foundation Virtual Gala

The Samuel Waxman Cancer Research Foundation (SWCRF) announced that the 44-year-old biomedical research non-profit will honor Leidos Chairman and Chief Executive Officer Roger A. Krone at its annual Collaborating for a Cure Gala. The SWCRF will honor Mr. Krone for his commitment to improving health and communities through philanthropy and his recognition as a global leader. The award will be presented at the virtual streaming of the SWCRF 23rd Collaborating for a Cure Gala on Thursday, November 19, 2020.

The tablet is also categorized as PDE-5 blocker that throw the blood in different parts of the body as well, such as levitra properien https://www.unica-web.com/archive/2009/result2009.html body strength and general health and also improving energy levels and concentrations, making great supplements for us all to use. Even though the testosterone usually term as a “male sex shop cialis hormone,” but the bodies of the women also require the specific quantity of it to sustain libido, control mood, and for increasing the energy levels. Although buy sildenafil without prescription the medication is considered safe for treating sexual dysfunction and other disorders. These days this remedies for ED, premature ejaculation, cialis 20mg generika low libido, impotence, etc.

“From addressing opioid addiction to supporting military veterans, Roger and Leidos have a track record of leading philanthropic and community support to address some of today’s most urgent health and social challenges. Also, Leidos is at the forefront of health information technology and innovative research of cancer, HIV, and infectious diseases. We are delighted to recognize Roger for his support of the SWCRF and our quest to realize a world without cancer,” said Samuel Waxman, M.D., Founder and Chief Executive Officer at SWCRF.

“It’s an honor to be recognized by the Samuel Waxman Cancer Research Foundation,” said Mr. Krone. “The Frederick National Laboratory for Cancer Research, currently operated by Leidos Biomedical Research on behalf of  the National Cancer Institute, works on the forefront of basic, translational and clinical science. I am confident with the great minds at labs like Frederick, and with the generosity of caring people like you, we will decode cancer once and for all. Thank you again for this honor.”

Mr. Krone leads Leidos, a Fortune 500® information technology, engineering, and science solutions and services leader working to solve the world’s toughest challenges in the defense, intelligence, homeland security, civil and health markets. Headquartered in Reston, Virginia, the company and its 38,000 employees support vital missions for government and commercial customers. Leidos Biomedical Research is a wholly owned subsidiary of Leidos.

The SWCRF Collaborating for a Cure Gala is one of New York City’s most anticipated holiday charity events that typically attracts more than 1,000 guests. To date, the event has raised more than $40 million for cancer research. This year, the Gala will be held virtually to raise $2 million to maintain the SWCRF’s more than 50 research programs and collaborations. The virtual event will feature an award presentation, appearances from some of the SWCRF’s most notable supporters, and a retrospective of past musical performances by some of the world’s most iconic musical legends.

For questions about the Collaborating for a Cure Gala, making a donation, or accessing the virtual livestream, contact the SWCRF at 212-867-4502, or visit www.waxmancancer.org/events/waxman-gala.

About Samuel Waxman Cancer Research Foundation:

The Samuel Waxman Cancer Research Foundation (SWCRF) is an international nonprofit organization dedicated to curing and preventing cancer. The Foundation is a pioneer in cancer research and its mission is to eradicate cancer by funding cutting-edge research that identifies and corrects abnormal gene function that causes cancer and develops minimally toxic treatments for patients. Through the Foundation’s collaborative group of world-class scientists, the Institute Without Walls, investigators share information and tools to speed the pace of cancer research. Since its inception in 1976, the Samuel Waxman Cancer Research Foundation has awarded more than $100 million to support the work of more than 200 researchers across the globe. For more information about the SWCRF research, visit www.waxmancancer.org.

Facebook:         WaxmanCancer https://www.facebook.com/WaxmanCancer

Instagram:        @waxmancancer https://www.instagram.com/waxmancancer/ Twitter:          @waxmancancer https://twitter.com/WaxmanCancer